Protagenic Therapeutics updates auditor consent for Phytanix acquisition; no material news

Protagenic Therapeutics, Inc.new

Company files Exhibit 23.1 with consent of GreenGrowth CPAs Inc.
Financial statements and pro forma data from prior filing remain unchanged.
Acquisition of Phytanix Bio was previously reported on May 19, 2025.

item 9.01

Source: SEC EDGAR

accession 0001493152-25-013851

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.